The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.50
Bid: 270.00
Ask: 275.00
Change: 2.50 (0.93%)
Spread: 5.00 (1.852%)
Open: 270.00
High: 272.50
Low: 270.00
Prev. Close: 270.00
ANP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Statement

9 Jan 2023 07:00

RNS Number : 0159M
Anpario PLC
09 January 2023
 
 Anpario plc("Anpario" or the "Group")

 

Full Year Trading Statement

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2022.

 

Trading update

The Group experienced a weaker than expected final quarter, and in particular December's performance was adversely affected by several factors including our Chinese subsidiary where customer orders were impacted by the spread of Covid following the relaxation of restrictions. Other factors included orders which left the factory on time but were delayed at the port due to last minute shipping schedule changes and therefore missed the statutory cut-off period and certain other orders waiting for letters of credit and import permits which are now expected in early 2023.

 

During the year the Group experienced significant headwinds including raw material and logistics costs increases which reduced our margins, although margins did improve in the second half. Our customers have also been impacted by cost pressures, notably feed and energy, which is hurting their profitability and, in some cases, viability leading to reduced volumes of our products.

 

As previously announced in our interim report in September, the Group had legal and professional costs in relation to specific acquisition opportunities that did not proceed. For the full-year results, due to the exceptional and non-recurring nature of these costs, they will be excluded from our alternative profit measures such as adjusted EBITDA.

 

As a result of these factors, and subject to audit, we expect full year sales to be at least £33m and adjusted EBITDA1 to be not less than £5m.

 

We expect the global economy to continue to be challenging, however, we are encouraged by the improvement in our gross margins in recent months as a result of our actions to increase sales prices and are experiencing an easing of raw material price inflation, both of which are helping the Group to rebuild its margins. We continue to invest in our global sales teams and product development which will help deliver profitable growth of the Group.

Financial position

Our financial position remains strong with year-end cash balances of £13.6m (30 Jun 2022: £13.3m). Through the second half of the year we increased cash by £0.3m, after £2.2m of dividend payments and further capital investments. Global logistics have been challenging over the past 18 months and in order to ensure supply to our customers we built up contingency in our inventory. However, the situation has started to improve and as such we have been able to start to reduce our working capital requirements and this process will continue into the new year.

 

Final results date

The Group expects to announce its final results for the year ended 31 December 2022 on 22 March 2023.

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Group's obligations under Article 17 of MAR.

 

 

1 Adjusted EBITDA represents operating profit for the year adjusted for: acquisition costs; share based payments and associated costs; and depreciation, amortisation and impairment charges.

 

 

 

Enquiries

 

Anpario plc

 

Richard Edwards, CEO

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

 

 

Peel Hunt LLP (NOMAD)

+44(0)20 7418 8900

Adrian Trimmings

 

Andrew Clark

 

Lalit Bose

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUAAGUPWPUR
Date   Source Headline
11th Aug 20107:00 amBUSTrading Statement
29th Jul 20105:47 pmBUSHolding(s) in Company
30th Jun 201011:58 amRNSResult of AGM
15th Jun 20105:17 pmRNSHolding(s) in Company
8th Jan 20102:34 pmRNSChange of Registered Office
13th Nov 20092:16 pmRNSDirectorate Change
13th Nov 20092:10 pmRNSPayment of dividend and proceeds of redemption
5th Nov 20092:01 pmRNSDe-listing from LSE
29th Oct 20092:00 pmRNSDividend Declaration
28th Oct 20092:19 pmRNSDirectorate Change
13th Aug 200912:00 pmRNSDirector/PDMR Shareholding
6th Aug 200911:39 amRNSDirector/PDMR Shareholding
27th Jul 20097:00 amRNSAnglo Platinum Interim Results
27th Jul 20097:00 amRNSAnglo Platinum Interim Results
24th Jul 20093:00 pmRNSDirectorate Change
17th Jul 200912:00 pmRNSChange to the Board of Directors
9th Jul 200910:58 amRNSBlocklisting Interim Review
9th Jul 200910:57 amRNSBlocklisting Interim Review
24th Jun 20094:00 pmRNSDirector/PDMR Shareholding
5th Jun 20092:58 pmRNSDealings by a director of major subsidiary
4th Jun 20093:08 pmRNSDirector/PDMR Shareholding
14th May 20093:01 pmRNSBEE transaction revised terms
30th Apr 20098:25 amRNSQuarterly Review and Production Report
29th Apr 200912:00 pmRNSDeclaration of preference dividend
30th Mar 20094:00 pmRNSResults of AGM
26th Mar 20099:24 amRNSNotice of AGM
13th Mar 200911:29 amRNSDirector/PDMR Shareholding
5th Mar 200911:10 amRNSDirectorate Change
12th Feb 20099:24 amRNSDirector/PDMR Shareholding
9th Feb 200910:38 amRNSFinal Results
9th Feb 20097:00 amRNSAnglo Platinum Results
9th Feb 20097:00 amRNSFinal Results
6th Jan 20092:14 pmRNSDirectorate Change
6th Jan 20097:00 amRNSBlocklisting Interim Review
6th Jan 20097:00 amRNSBlocklisting Interim Review
15th Dec 20083:30 pmRNSDirector/PDMR Shareholding
8th Dec 20083:30 pmRNSTiming of capex review
12th Nov 20089:30 amRNSAgreements with Anglo Platinum & Northam Platinum
5th Nov 20082:32 pmRNSSmelter Shutdown
4th Nov 20082:00 pmRNSDirector/PDMR Shareholding
27th Oct 20082:00 pmRNSDividend Declaration
23rd Oct 20082:57 pmRNSBEE restructuring agreement
23rd Oct 20087:00 amRNSAnglo Platinum Quarterly Review and Prod Report
23rd Sep 200812:00 pmRNSDirectorate Change
20th Aug 20089:42 amRNSDividend Declaration
1st Aug 20084:30 pmRNSDirector/PDMR Shareholding
28th Jul 20088:00 amRNSInterim Results
28th Jul 20088:00 amRNSAnglo Platinum Limited
23rd Jul 200812:32 pmRNSBlocklisting Interim Review
18th Jul 20082:32 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.